Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Pied Piper who wrote (2000)	10/24/2007 11:30:40 AM
From: Jibacoa	Respond to of 3722

CEPH is among the few that's trying to stay out of the red tide that's engulfing most of the stocks today.<g> The stock opened with an UG & is still up around 4% bigcharts.marketwatch.com It announced yesterday some positive results on its PIII of Treanda, on NHL patients that are no longer responsive tu Rituxan. biz.yahoo.com In Sep CEPH submitted an NDA requesting approval of Treanda for the treatment of patients with CLL, for which the FDA has granted orphan drug status. The stock has some resistance at the $77 & the $82 to $84 level before it can make an all time H <g> bigcharts.marketwatch.com Bernard

To: Pied Piper who wrote (2000)	10/24/2007 1:00:57 PM
From: Jibacoa	Respond to of 3722

Yes, FMTI has increased its guidance some & in August it announced that UPEC, the largest non-alcoholic drinks producer in Taiwan, had launched a cholesterol-lowering milk drink incorporating its Reducol. But it seems it will have to make a RS or some other move if it wants to continue its NAZ listing.<g> It has a good amount of resistance at the $0.80 level before it can try to close its Dec DG.On Dec 4, was when it announced that its FM-VP4 didn't achieve the goal of a 15% reduction in LDL from baseline.<g> bigcharts.marketwatch.com Bernard